Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer
ICI rechallenge showed a survival benefit, particularly in NSCLC patients with NLR < 3.8, good ECOG PS, and objective response.
Authors
- Ekaterina P. Solovyova
- С. В. Орлов (ORCID: https://orcid.org/0000-0001-6080-8042)
- Karina Oganyan (ORCID: https://orcid.org/0000-0002-2743-0882)
- A. A. Musaelyan (ORCID: https://orcid.org/0000-0002-7570-2256)
- Magaripa A. Urtenova
- Svetlana V. Odintsova (ORCID: https://orcid.org/0000-0001-5591-7746)
- L. I. Menshikovа
Institutions
- First Pavlov State Medical University of St. Petersburg (RU)
- Kurchatov Institute (RU)
- Federal Almazov North-West Medical Research Centre (RU)
Publication Details
- Journal
- Exploration of Targeted Anti-tumor Therapy
- Published
- 2024-10-18
- DOI
- https://doi.org/10.37349/etat.2024.00275
- Citations
- 8
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.26
Funders
- Vrije Universiteit Amsterdam